TRT Aveed denied as not FDA-approved for this use by Humana?

Humana's specific coverage criteria for trt aveed are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied Aveed as Not FDA-Approved

This denial reason is almost certainly an administrative or claim-coding error. Aveed (testosterone undecanoate injection) holds FDA approval for testosterone replacement therapy in men with hypogonadism. If Humana issued a "not FDA-approved" denial, the most likely explanations are: (1) an incorrect NDC code was submitted on the claim, (2) the drug was coded as an off-label use due to a diagnosis coding mismatch, or (3) the denial template was applied in error. Regardless of cause, this denial is directly rebutted by the public FDA record.

## Why This Denial Is Appealable

FDA approval is a matter of federal public record. Aveed's approval status and labeled indication are documented in the FDA's official prescribing information and in the DailyMed database. Any Humana denial asserting non-FDA-approval for an on-label use of Aveed is factually incorrect and must be reversed on appeal. This is typically one of the fastest denial types to overturn.

## Federal Appeal Framework

• Internal appeal: File within 180 days of the denial date. Given the factual nature of the error, also consider calling Humana's member services immediately to request expedited administrative correction before filing a formal appeal.
• Standard response window: Humana must respond within 30 days (standard) or 72 hours (expedited).
• External review (ACA §2719 / ERISA §503): If the internal appeal is not resolved in your favor within the required timeframe, you have approximately 4 months from the final adverse determination to request independent external review.

## Documentation to Gather

1. FDA-approved prescribing label — Download the current full prescribing information for Aveed from the FDA's DailyMed database (dailymed.nlm.nih.gov). Print or save the page showing the drug name, approval date, and approved indication. This is your primary evidence. 2. Claim and prior authorization paperwork — Obtain the original claim submission, prior authorization request, and the denial letter. Check that the NDC code, diagnosis code (ICD-10), and procedure/drug code are all correct. A single coding error can trigger an automated "not approved" flag. 3. Diagnosis confirmation — Chart documentation of the hypogonadism diagnosis, confirming the prescribed use matches the FDA-approved indication. 4. Prescriber cover letter — A brief letter from the prescribing physician noting the FDA approval status, the on-label indication, the patient's diagnosis, and the request for immediate reversal. 5. Aveed REMS documentation — Because Aveed is subject to a FDA Risk Evaluation and Mitigation Strategy (REMS), including documentation of REMS-certified prescriber and administration site can preempt any secondary concern about the drug's status.

## Criteria-Mapping Structure

| Denial Assertion | Rebuttal | |---|---| | "Not FDA approved" | FDA DailyMed entry + approval date for Aveed (testosterone undecanoate) | | Use is off-label | Diagnosis code in chart matches FDA-approved indication | | Claim coding | Correct NDC and ICD-10 codes confirmed with prescriber's billing staff |

If the internal appeal is not resolved quickly, escalate by filing a complaint with your state's insurance commissioner and, if applicable, the U.S. Department of Labor (ERISA plans) or CMS (Medicare Advantage). Regulators take factual FDA-status errors seriously.